Clinical criteria of infection with Staphylococcus aureus and Pseudomonas aeruginosa;Critères cliniques de l'infection à Staphylococcus aureus et à Pseudomonas aeruginosa

Revue des Maladies Respiratoires

Volumn 20, Issue 2 II, 2003, Pages

  Bremont F ^a  

^a HÔPITAL DES ENFANTS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENTEEISM; APPETITE DISORDER; ARTERIAL CARBON DIOXIDE TENSION; BRONCHITIS; CLINICAL FEATURE; CONFERENCE PAPER; CYANOSIS; DISEASE EXACERBATION; DYSPNEA; EXERCISE; GRAM NEGATIVE INFECTION; HEART RHYTHM; HEMOPTYSIS; HUMAN; LUNG INFECTION; NONHUMAN; NOSE CONGESTION; PSEUDOMONAS AERUGINOSA; RESPIRATORY SYSTEM; RESPIRATORY TRACT INFECTION; RHINITIS; SPUTUM ANALYSIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; THORAX RADIOGRAPHY; WHEEZING; CYSTIC FIBROSIS; DIFFERENTIAL DIAGNOSIS; MICROBIOLOGY; PATHOGENICITY; REFERENCE VALUE; REVIEW;

CYSTIC FIBROSIS; DIAGNOSIS, DIFFERENTIAL; HUMANS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; REFERENCE VALUES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 0141939470     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (30)

1. Buret A, Cripps A: The immunoevasive activities of Pseudomonas aeruginosa. Relevance for Cystic fibrosis. Am Rev Respir Dis 1993; 148: 793-805.
2. Baltimore R, Christie C, Smith G: Immunohistopathologic localization of Pseudomonas aeruginosa in the lung of patients with Cystic fibrosis. Pediatric Pulmonology 1988; Supp 2: A 69.
3. Potts S, Roggli V, Spock A: Immunohistologic quantification of Pseudomonas aeruginosa in the tracheobronchial tree from patients with Cystic fibrosis. Pediatr Pathol Lab Med 1995; 15: 707-21.
4. Evans D, Fiedler M: Lung bascess in a patient with Cystic fibrosis: a case report and review of the literature. Pediatr Pulmonol 1996; 21: 337-40.
5. Cooper D, Russell L, Henry R: Cerebral abscess as a complication of Cystic fibrosis. Pediatr Pulmonol 1994; 17: 390-2.
6. Tirouvanziam R, De Bentzmann S, Bubeau C, Hinnrasky J, Jacquot J, Peault B, Puchelle E: Inflammation and infection in naive human Cystic fibrosis airway grafts. Am J Respir Cell Mol Biol 2000; 23: 121-7.
7. Khan T, Wagener J, Bost T, Martinez F, Accurso F: Early pulmonary inflammation in cystic fibroisis. Am J Respir Crit Care Med 1995; 151: 1075-82.
8. Rosenfeld M, Gibson R, Mcnamar S, Emerson J, Burns J, Castile R, Hiatt P, Mccoy K, Wilson C, Inglis A, Smith A, Martin T, Ramsey B: Early pulmonary infection, inflammation and clinical outcomes in infants with Cystic fibrosis. Pediatr Pulmonol 1001; 32: 356-66.
9. Doting G, Hoiby N: Longitudinal study of immune response to Pseudomonas aeruginosa antigens in Cystic fibrosis. Infect Immun 1983; 42: 197-201.
10. Johansen H, Hoiby N: Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with Cystic fibrosis in Denmark. Thorax 1992; 47: 109-11.
11. Wedzicha J: Exacerbations: etiology and pathophysiologic mechanisms. Chest 2002; 121; 5: 136S-141S.
12. Smyth A, Smyth R, Tong C, Hart C, Heaf D: Effect of respiratory virus infections including rhinovirus on clinical status in Cystic fibrosis. Arch Dis Child 1995; 73: 117-20.
13. Kerem E, Corey M, Gold R, Levison H: Pulmonary function and clinical course in patients with Cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa. J Pediatr 1990; 116: 714-9.
14. De Rose V: Mechanisms and markers of airway inflammation in Cystic fibrosis. Eur Respir J 2002; 19: 333-40.
15. Wojnarowski C, Frischer T, Hofbauer E, Grabner C, Mosgoeller W, Eichler I, Ziesche R: Cytokine expression in bronchial biopsie of cystictic fibrosis patients with and without acute exacerbations. Eur Respir J 1999; 14: 1136-44.
16. Gold R, Carpenter S, Heuter H, Corey M, Levison H: Randomized trial of ceftazidime versus placebo in mangement of acute respiratory exacerbations in patients with Cystic fibrosis. J Pediatr 1987; 111(6 pt 1): 907-13.
17. Chodosh S, Mccarty J, Farkas S, Drehobl M, Tosiello R, Shan M, Aneiro L, Kowalsky S: Related Articles, Links Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group. Clin Infect Dis 1998; 27: 722-9.
18. Miravitlles M: Exacerbation of chronic obstructive pulmonary disease: when are bacteria important? Eur Respir J 2002; 20: Suppl. 36: 9S-19S.
19. Smith A, Redding G, Doershuk C, Goldmann D, Gore E, Hilman B, Marks M, Moss R, Ramsey B, Rubio T, Schwartz R, Thomassen M, Williams-Warren J, Weber A, Wilmott R, Wilson D, Yogev R: Sputum changes associated with therapy for endobronchial exacerbation in Cystic fibrosis. J Pediatr 1988; 112: 547-54.
20. Fuchs H, Borowitz D, Christiassen D, Morris E, Nash M, Ramsey B, Rosenstein B, Smith A, Wohl M: Effect of aerosolized recombinant human Dnase on exacerbations of respiratory symptoms and on pulmonary function in patients with Cystic fibrosis. N Engl J Med 1994; 331: 637-42.
21. Wilmott R, Amin R, Colin A, Devault A, Dozor A, Eigen H, Johnson C, Lester L, Mccoy K, Moss R, Nash M, Pagel Jue C, Regelmann W, Stokes D, Fuchs H: Aerosolized recombinant human Dnase in hospitalized Cystic fibrosis with acute pulmonary excerbations. Am J Respir Crit Care Med 1996; 153: 1914-7.
22. Dakin C, Henry R, Field P, Morton J: Defining an exacerbation of pulmonary disease in Cystic fibrosis. Pediatr Pulmonol 2001; 31: 436-42.
23. Kanga J, Kuhn R, Craigmyle L, Haverstock D, Church D: Cystic fibrosis clinical score: a new scoring system to evaluate acute pulmonary exacerbation. Clinical therapeutics 1999; 21: 1343-56.
24. Ramsey B, Boat T, Consensus Group: Outcome measures for clinical trials in Cystic fibrosis. J Pediatr 1994; 124: 177-92.
25. Rosenfeld M, Emerson J, Williams-Warren J, Pepe M, Smith A, Montgomery B, Ramsey B: Defining a pulmonary exacerbation in Cystic fibrosis. J Pediatr 2001; 139: 359-65.
26. Beaudry P, Marks M, Mcdougall D, Desmond K, Rangel R: Is anti-pseudomonas therapy warranted in acute respiratory exacerbations in children with Cystic fibrosis? Pediatrics 1980; 97: 144-7.
27. Valetta E, Rigo A, Bonazzi L, Zanolla L, Mastella G: Modification of some markers of inflammation during treatment for acute respiratory exacerbation in Cystic fibrosis. Acta Paediatr 1992; 81: 227-30.
28. Robinson T, Leung A, Northway W, Blankenberg F, Bloch D, Ochlert J, Al-Dabbagh H, Hubli S, Moss R: Spirometer-trigegerd high resolution computed tomography and pulmonary function measurements during an acute exacerbation in patients with Cystic fibrosis. J Pediatr 2001; 138: 553-9.
29. Hommick D, Anderson K, Marks J: Comparaison of the flutter device to standard chest phyiotherapy in hospitalized patients with Cystic fibrosis. A pilot study. Chest 1998; 114: 993-7.
30. Mastella G, Agostini M, Barlocco G, Bonomi U, Borgo G, Bozzino L, Cabrini G, Cappellettini L, Castellani L, Conforti M, Marazzani S, Martini N, Montermezzi P, Paulon G, Pederzini F, Cancassani L, Scroccaro G: Alternative antibiotics for the treatment of pseudomonas infections in Cystic fibrosis. J Antimicrob Chemother 1983; 12: 297-311.